BMY
BMY
NYSE · Pharmaceuticals

Bristol-Myers Squibb Co

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield
$58.94
+1.55 (+2.70%)
As of Mar 25, 9:31 PM ET ·
Analyst Consensus
Hold
36
Analysts
Very High
Coverage
Buy 15 42%
Hold 19 53%
Sell 2 6%
Price Target
Analyst Price Target +196.1% upside
Low Target $130.78
Average Target $174.50
High Target $195.10
Current Price $58.94
Current
$58.94
Target
$174.50
$130.78 $174.50 avg $195.10
Scenario Analysis
Bear Case
$130.78
121.9%
Low target
Base Case
$174.50
+196.1%
Avg target
Bull Case
$195.10
+231.0%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$62.89
-6.3% from high
52-Week Low
$42.52
+38.6% from low
50-Day SMA
$55.66
+5.9% vs SMA
200-Day SMA
$49.00
+20.3% vs SMA
RSI (14)
74.1
Overbought
Target vs 52W High
$174.50
+177.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%